Literature DB >> 1893804

Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.

C Merkel1, A Gatta, M Zoli, M Bolognesi, P Angeli, T Iervese, G Marchesini, A Ruol.   

Abstract

Seventy-eight patients with cirrhosis were prospectively followed for up to 20 months, on the average. At entry into the study, galactose elimination capacity, aminopyrine breath test, and ICG clearance were measured. At the end of the study, 27 patients had died. Univariate analysis using the Kaplan-Meier method showed that both quantitative liver function tests (galactose elimination capacity: P less than 0.025; aminopyrine breath test: P less than 0.001; ICG clearance: P less than 0.005) and common clinical and biochemical data (encephalopathy: P less than 0.001; ascites: P less than 0.001; serum bilirubin: P less than 0.005; serum albumin: P less than 0.001; prothrombin index: P less than 0.05) were significant predictors of survival. To investigate whether quantitative liver function tests could contribute to a better definition of the prognosis, once Pugh score had already been taken into account, a multiple regression analysis according to the Cox model was performed. Pugh score and galactose elimination capacity resulted in the only independent prognostic covariates. From them a prognostic index was calculated, and the model was validated in an additional sample of 70 patients investigated according to the same protocol. The contribution GEC gave to the assessment of overall prognosis over that obtained using the Pugh score was slight, as estimated by the statistical parameters of the Cox's model, but was significant as assessed by a ROC curve analysis (P = 0.05). These data show that all quantitative liver function tests were predictors of survival in cirrhosis, and that the galactose elimination capacity added some new prognostic information to those already available using the Child-Turcotte-Pugh classification.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1893804     DOI: 10.1007/bf01307508

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Hepatic clearance and liver blood flow.

Authors:  S Keiding
Journal:  J Hepatol       Date:  1987-06       Impact factor: 25.083

2.  Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity.

Authors:  H Orrego; Y Israel; J E Blake; A Medline
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

3.  Prognostic factors in cirrhosis identified by Cox's regression model.

Authors:  P Schlichting; E Christensen; P K Andersen; L Fauerholdt; E Juhl; H Poulsen; N Tygstrup
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

4.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

5.  Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis.

Authors:  I Albers; H Hartmann; J Bircher; W Creutzfeldt
Journal:  Scand J Gastroenterol       Date:  1989-04       Impact factor: 2.423

6.  Survival and prognostic indicators in compensated and decompensated cirrhosis.

Authors:  G D'Amico; A Morabito; L Pagliaro; E Marubini
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

7.  Aminopyrine demethylation measured by breath analysis in cirrhosis.

Authors:  J Bircher; A Küpfer; I Gikalov; R Preisig
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

8.  Factors influencing survival at one year in patients with nonbiliary hepatic parenchymal cirrhosis.

Authors:  M Adler; J Van Laethem; A Glibert; M Gelin; N Bourgeois; P Vereerstraeten; M Cremer
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

9.  [Multidimensional analysis by Cox's model of the survival of patients with alcoholic cirrhosis].

Authors:  J P Pignon; T Poynard; S Naveau; P Marteau; O Zourabichvili; J C Chaput
Journal:  Gastroenterol Clin Biol       Date:  1986 Jun-Jul

10.  The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis.

Authors:  J Lindskov
Journal:  Acta Med Scand       Date:  1982
View more
  19 in total

1.  Influence of low-dose oral contraceptives, alcohol, and grapefruit on.

Authors:  H Van Vlierberghe; F Van Durme; H Verdievel; M Dhont; M de Vos; A Elewaut
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Age-dependency of galactose elimination capacity in healthy children and children with chronic liver disease.

Authors:  Aksel Lange; Henning Grønbæk; Hendrik Vilstrup; Susanne Keiding
Journal:  Scand J Gastroenterol       Date:  2010-11-01       Impact factor: 2.423

3.  Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis.

Authors:  Maximilian Jara; Tomasz Dziodzio; Maciej Malinowski; Katja Lüttgert; Radoslav Nikolov; Paul Viktor Ritschl; Robert Öllinger; Johann Pratschke; Martin Stockmann
Journal:  Dig Dis Sci       Date:  2018-11-07       Impact factor: 3.199

4.  Preoperative galactose elimination capacity predicts complications and survival after hepatic resection.

Authors:  Claudio A Redaelli; Jean-François Dufour; Markus Wagner; Martin Schilling; Jürg Hüsler; Lukas Krähenbühl; Markus W Büchler; Jürg Reichen
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

5.  Could quantitative liver function tests gain wide acceptance among hepatologists?

Authors:  Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

6.  Preoperative imaging for hepatic resection of colorectal cancer metastasis.

Authors:  Timothy L Frankel; Richard Kinh Gian; William R Jarnagin
Journal:  J Gastrointest Oncol       Date:  2012-03

7.  The role of salivary caffeine clearance in the diagnosis of chronic liver disease.

Authors:  Anurag Tripathi; Brijesh Tiwari; Ranjit Patil; Vikram Khanna; Vandana Singh
Journal:  J Oral Biol Craniofac Res       Date:  2015-01-23

8.  The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.

Authors:  Peter Jepsen; Hendrik Vilstrup; Peter Ott; Susanne Keiding; Per K Andersen; Niels Tygstrup
Journal:  BMC Gastroenterol       Date:  2009-06-30       Impact factor: 3.067

9.  Enzymatic liver function capacity correlates with disease severity of patients with liver cirrhosis: a study with the LiMAx test.

Authors:  Maciej Malinowski; Maximilian Jara; Katja Lüttgert; James Orr; Johan Friso Lock; Eckart Schott; Martin Stockmann
Journal:  Dig Dis Sci       Date:  2014-07-04       Impact factor: 3.199

10.  Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis?

Authors:  Christoph Herold; Sabine Regn; Marion Ganslmayer; Matthias Ocker; Eckhart G Hahn; Detlef Schuppan
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.